Gaëtan Devos
Katholieke Universiteit Leuven
DissectionInternal medicineRadiologyUrologySurgerySeries (stratigraphy)OncologyPsychologyBiochemical recurrenceAndrogen deprivation therapyMetastasectomyMetastasisProstatectomyProstate cancerLymph nodeRecurrent prostate cancerIn patientSalvage radiationRadiation therapyMedicine
88Publications
10H-index
199Citations
Publications 83
Newest
#1Carlo Andrea Bravi (UniSR: Vita-Salute San Raffaele University)H-Index: 10
#2M. DroghettiH-Index: 3
Last. Riccardo SchiavinaH-Index: 38
view all 0 authors...
Abstract null null Background null The optimal definition and prognostic significance of persistently elevated prostate-specific antigen (PSA) after salvage lymph node dissection (sLND) for node-only recurrent prostate cancer (PCa) remain unknown. null null null Objective null To assess the definition and clinical implications of persistently elevated PSA after sLND for node-only recurrent PCa after radical prostatectomy. null null null Design, setting, and participants null The study included 5...
Source
#1Joël Billieux (UNIL: University of Lausanne)H-Index: 59
#2Alexandre Heeren (UCL: Université catholique de Louvain)H-Index: 28
Last. Gaëtan Devos (UCL: Université catholique de Louvain)H-Index: 10
view all 0 authors...
Aims null Negative and Positive urgency are emotion-related impulsivity traits that are thought to be transdiagnostic factors in psychopathology. However, it has recently been claimed that these two traits are closely related to each other and that considering them separately might have limited conceptual and methodological value. The present study aimed to examine whether positive and negative urgency constructs constitute separate impulsivity traits. null Methods null In contrast to previous s...
Source
#1Lorenzo Tosco (Katholieke Universiteit Leuven)H-Index: 13
#2Gaëtan Devos (Katholieke Universiteit Leuven)H-Index: 10
Last. Steven Joniau (Katholieke Universiteit Leuven)H-Index: 73
view all 0 authors...
Abstract null null Background null Despite the curative intent of radical prostatectomy (RP) (+/- radiotherapy (RT)), 30% of the clinically localized prostate cancer (CaP) patients will develop rising PSA (prostate specific antigen). In absence of clinical recurrence, there is a lack of effective treatment strategies in order to control the disease at its earliest (micro)metastatic stage. The aim of this study was to assess safety, tolerability, and biochemical response of off-label Radium-223 (...
Source
#1Gaëtan Devos (Katholieke Universiteit Leuven)H-Index: 10
#2Andries Clinckaert (Katholieke Universiteit Leuven)H-Index: 1
Last. Steven Joniau (Katholieke Universiteit Leuven)H-Index: 73
view all 4 authors...
Source
#1Charlien Berghen (Katholieke Universiteit Leuven)H-Index: 6
#2Steven Joniau (Katholieke Universiteit Leuven)H-Index: 73
Last. Gert De Meerleer (Katholieke Universiteit Leuven)H-Index: 6
view all 9 authors...
Abstract In metastatic castration-refractory prostate cancer (mCRPC), state-of-the-art treatment consists of androgen biosynthesis inhibition (abiraterone), inhibition of the androgen receptor (enzalutamide), chemotherapy, or radium-223 in combination with androgen deprivation therapy (ADT). A subgroup of these patients show oligoprogression, with the progression of only a limited number of metastatic spots, while all other metastases remain controlled by ongoing systemic therapy. In a bi-instit...
13 CitationsSource
#1Lisa Moris (Katholieke Universiteit Leuven)H-Index: 11
#2Gaëtan Devos (Katholieke Universiteit Leuven)H-Index: 10
Last. Steven Joniau (Katholieke Universiteit Leuven)H-Index: 73
view all 13 authors...
Introduction: Despite progress in the field of high-risk localized prostate cancer (HRPCa) treatments, high-risk patients treated with curative intent are at increased risk of biochemical recurrenc...
Source
#1Paolo Dell'OglioH-Index: 28
#2Elio Mazzone (UniSR: Vita-Salute San Raffaele University)H-Index: 11
Last. Alexandre MottrieH-Index: 34
view all 15 authors...
Abstract Background Evidence on the learning curve for robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) is limited. Objective To assess the effect of surgical experience (SE) on perioperative and intermediate-term oncological outcomes in a large contemporary cohort of RARC patients after accounting for the impact of intersurgeon variability. Design, setting, and participants The study cohort included 164 patients treated with RARC and ICUD by two surgeons bet...
7 CitationsSource
#1Wout DevliesH-Index: 5
#2Florian HandleH-Index: 11
Last. Frank ClaessensH-Index: 66
view all 5 authors...
Prostate cancer is an androgen-driven tumor. Different prostate cancer therapies consequently focus on blocking the androgen receptor pathway. Clinical studies reported tumor resistance mechanisms by reactivating and bypassing the androgen pathway. Preclinical models allowed the identification, confirmation, and thorough study of these pathways. This review looks into the current and future role of preclinical models to understand resistance to androgen receptor-targeted therapies. Increasing kn...
Source
#1Gaëtan Devos (Katholieke Universiteit Leuven)H-Index: 10
#2Bram Vansevenant (Katholieke Universiteit Leuven)
Last. Steven Joniau (Katholieke Universiteit Leuven)H-Index: 73
view all 12 authors...
CONTEXT There is an urgent need to develop novel treatment strategies in patients with unfavorable intermediate- and high-risk localized prostate cancer (PCa) to optimize the outcome of these patients. Androgen receptor signaling inhibitors (ARSI) have demonstrated a survival benefit in metastatic hormonesensitive and castration-resistant PCa. A similar benefit might be expected in the localized setting. OBJECTIVE To perform a systematic review about the role of neoadjuvant ARSI in unfavorable i...
Source
#1Gaëtan Devos (Katholieke Universiteit Leuven)H-Index: 10
#2Manuel Witters (Katholieke Universiteit Leuven)H-Index: 2
Last. Steven Joniau (Katholieke Universiteit Leuven)H-Index: 73
view all 13 authors...
BACKGROUND: Salvage radiotherapy (RT) (± androgen deprivation therapy (ADT)) is often used as a treatment in patients with biochemical recurrence (BCR) following radical prostatectomy (RP). Unfortunately, even after RT ± ADT, a significant number of patients will develop 'second' BCR. The aim of this study was to investigate the impact of postoperative treatments (adjuvant/salvage radiotherapy (RT) ± androgen deprivation therapy) on the recurrence pattern in patients with BCR following RP assess...
2 CitationsSource